TriSalus Life Sciences, Inc. (TLSI) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TLSI Revenue Growth
TLSI Revenue Analysis (2020–2025)
As of May 8, 2026, TriSalus Life Sciences, Inc. (TLSI) generated trailing twelve-month (TTM) revenue of $45.2 million, reflecting explosive growth of +59.8% year-over-year. The most recent quarter (Q4 2025) recorded $13.2 million in revenue, up 14.2% sequentially.
Looking at the longer-term picture, TLSI's historical revenue data shows a 3-year CAGR of +53.9%. The company achieved its highest annual revenue of $45.2 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), ANGO (+7.3% YoY), and IRTC (+27.4% YoY), TLSI has outperformed the peer group in terms of revenue growth. Compare TLSI vs NVCR →
TLSI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TLSICurrent | $45M | +59.8% | - | -59.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 IRTC | $747M | +27.4% | +23.0% | -4.9% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 CNMD | $1.4B | +4.4% | +9.8% | 10.3% |
TLSI Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $45.2M | +53.4% | $38.2M | 84.6% | $-26,946,000 | -59.7% |
| 2024 | $29.4M | +59.0% | $25.3M | 86.1% | $-36,165,000 | -122.9% |
| 2023 | $18.5M | +49.3% | $15.9M | 85.9% | $-54,475,000 | -294.3% |
| 2022 | $12.4M | +47.6% | $10.1M | 81.8% | $-36,439,000 | -293.9% |
| 2021 | $8.4M | - | $7.2M | 85.8% | $-24,032,000 | -286.1% |
| 2020 | $0 | - | $0 | - | $-108,493 | - |
See TLSI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TLSI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TLSI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTLSI — Frequently Asked Questions
Quick answers to the most common questions about buying TLSI stock.
Is TLSI's revenue growth accelerating or slowing?
TLSI revenue is accelerating at +59.8% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $45M. Growth momentum has increased versus prior periods.
What is TLSI's long-term revenue growth rate?
TriSalus Life Sciences, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +59.8% is above this long-term average.
How is TLSI's revenue distributed by segment?
TLSI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.